March 15, 2021 by Chain Drug Review
COVID-19, COVID-19 vaccines, Food and Drug Administration (FDA)
March 15, 2021, News
NEW YORK — As the country races to build up enough herd immunity to finally defeat the COVID-19 pandemic, the momentum in distributing the volume of vaccines to meet that goal got a significant boost recently with news that the Food and Drug Administration approved the Johnson & Johnson’s coronavirus vaccine for emergency use. Retailers
October 19, 2020 by Chain Drug Review
COVID-19, Food and Drug Administration (FDA)
News, October 19, 2020
NEW YORK — Controversy over COVID-19 protocols seems to be spreading as fast as the virus itself — as is concern over who is getting infected. Most notably, of course, was news that President Donald Trump was stricken with the virus and was flown to Walter Reed Hospital for monitoring. Many of the president’s inner
January 20, 2020 by Mike Krouskos
cannabidiol (CBD), CBD, Food and Drug Administration (FDA), Veritas Farms
January 20, 2020, Opinion
In the health and wellness market, hemp-based products are becoming mainstream. Many large and small retailers including drug, grocery, convenience, cosmetic and clothing stores have been attracted to the hemp space and carry lines of hemp/CBD products. In fact, since the production of hemp was legalized as an agricultural commodity with the 2018 Farm Bill,
January 3, 2020 by Chain Drug Review
Alex Azar, Dr. Stephen Hahn, e-cigarette products that appeal to kids, Food and Drug Administration (FDA), including fruit and mint flavors
Leading Headlines
SILVER SPRING, Md. — Amid the epidemic levels of youth use of e-cigarettes and the popularity of certain products among children, the U.S. Food and Drug Administration has issued a policy prioritizing enforcement against certain unauthorized flavored e-cigarette products that appeal to kids, including fruit and mint flavors. Under this policy, companies that do not cease
October 2, 2019 by Chain Drug Review
Dr. Janet Woodcock, Food and Drug Administration (FDA), NABP president Jack “Jay” Campbell, Prescription drug compounding, The National Association of Boards of Pharmacy (NABP)
Leading Headlines, Pharmacy
MOUNT PROSPECT, Ill. — The National Association of Boards of Pharmacy (NABP) announced it has been awarded funding from Food and Drug Administration (FDA) to create a data system to assist with the collection of critical information to protect public health. The new system will enable the collection, management, and sharing of information regarding compounding